Florida Senate - 2023 SB 736
By Senator Brodeur
10-00876-23 2023736__
1 A bill to be entitled
2 An act relating to controlled substances; amending s.
3 893.03, F.S.; adding nitazene derivatives to the list
4 of Schedule I controlled substances; providing an
5 effective date.
6
7 Be It Enacted by the Legislature of the State of Florida:
8
9 Section 1. Paragraph (a) of subsection (1) of section
10 893.03, Florida Statutes, is amended to read:
11 893.03 Standards and schedules.—The substances enumerated
12 in this section are controlled by this chapter. The controlled
13 substances listed or to be listed in Schedules I, II, III, IV,
14 and V are included by whatever official, common, usual,
15 chemical, trade name, or class designated. The provisions of
16 this section shall not be construed to include within any of the
17 schedules contained in this section any excluded drugs listed
18 within the purview of 21 C.F.R. s. 1308.22, styled “Excluded
19 Substances”; 21 C.F.R. s. 1308.24, styled “Exempt Chemical
20 Preparations”; 21 C.F.R. s. 1308.32, styled “Exempted
21 Prescription Products”; or 21 C.F.R. s. 1308.34, styled “Exempt
22 Anabolic Steroid Products.”
23 (1) SCHEDULE I.—A substance in Schedule I has a high
24 potential for abuse and has no currently accepted medical use in
25 treatment in the United States and in its use under medical
26 supervision does not meet accepted safety standards. The
27 following substances are controlled in Schedule I:
28 (a) Unless specifically excepted or unless listed in
29 another schedule, any of the following substances, including
30 their isomers, esters, ethers, salts, and salts of isomers,
31 esters, and ethers, whenever the existence of such isomers,
32 esters, ethers, and salts is possible within the specific
33 chemical designation:
34 1. Acetyl-alpha-methylfentanyl.
35 2. Acetylmethadol.
36 3. Allylprodine.
37 4. Alphacetylmethadol (except levo-alphacetylmethadol, also
38 known as levo-alpha-acetylmethadol, levomethadyl acetate, or
39 LAAM).
40 5. Alphamethadol.
41 6. Alpha-methylfentanyl (N-[1-(alpha-methyl-betaphenyl)
42 ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4
43 (N-propanilido) piperidine).
44 7. Alpha-methylthiofentanyl.
45 8. Alphameprodine.
46 9. Benzethidine.
47 10. Benzylfentanyl.
48 11. Betacetylmethadol.
49 12. Beta-hydroxyfentanyl.
50 13. Beta-hydroxy-3-methylfentanyl.
51 14. Betameprodine.
52 15. Betamethadol.
53 16. Betaprodine.
54 17. Clonitazene.
55 18. Dextromoramide.
56 19. Diampromide.
57 20. Diethylthiambutene.
58 21. Difenoxin.
59 22. Dimenoxadol.
60 23. Dimepheptanol.
61 24. Dimethylthiambutene.
62 25. Dioxaphetyl butyrate.
63 26. Dipipanone.
64 27. Ethylmethylthiambutene.
65 28. Etonitazene.
66 29. Etoxeridine.
67 30. Flunitrazepam.
68 31. Furethidine.
69 32. Hydroxypethidine.
70 33. Ketobemidone.
71 34. Levomoramide.
72 35. Levophenacylmorphan.
73 36. Desmethylprodine (1-Methyl-4-Phenyl-4
74 Propionoxypiperidine).
75 37. 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4
76 piperidyl]-N-phenylpropanamide).
77 38. 3-Methylthiofentanyl.
78 39. Morpheridine.
79 40. Noracymethadol.
80 41. Norlevorphanol.
81 42. Normethadone.
82 43. Norpipanone.
83 44. Para-Fluorofentanyl.
84 45. Phenadoxone.
85 46. Phenampromide.
86 47. Phenomorphan.
87 48. Phenoperidine.
88 49. PEPAP (1-(2-Phenylethyl)-4-Phenyl-4
89 Acetyloxypiperidine).
90 50. Piritramide.
91 51. Proheptazine.
92 52. Properidine.
93 53. Propiram.
94 54. Racemoramide.
95 55. Thenylfentanyl.
96 56. Thiofentanyl.
97 57. Tilidine.
98 58. Trimeperidine.
99 59. Acetylfentanyl.
100 60. Butyrylfentanyl.
101 61. Beta-Hydroxythiofentanyl.
102 62. Fentanyl derivatives. Unless specifically excepted,
103 listed in another schedule, or contained within a pharmaceutical
104 product approved by the United States Food and Drug
105 Administration, any material, compound, mixture, or preparation,
106 including its salts, isomers, esters, or ethers, and salts of
107 isomers, esters, or ethers, whenever the existence of such salts
108 is possible within any of the following specific chemical
109 designations containing a 4-anilidopiperidine structure:
110 a. With or without substitution at the carbonyl of the
111 aniline moiety with alkyl, alkenyl, carboalkoxy, cycloalkyl,
112 methoxyalkyl, cyanoalkyl, or aryl groups, or furanyl,
113 dihydrofuranyl, benzyl moiety, or rings containing heteroatoms
114 sulfur, oxygen, or nitrogen;
115 b. With or without substitution at the piperidine amino
116 moiety with a phenethyl, benzyl, alkylaryl (including
117 heteroaromatics), alkyltetrazolyl ring, or an alkyl or
118 carbomethoxy group, whether or not further substituted in the
119 ring or group;
120 c. With or without substitution or addition to the
121 piperdine ring to any extent with one or more methyl,
122 carbomethoxy, methoxy, methoxymethyl, aryl, allyl, or ester
123 groups;
124 d. With or without substitution of one or more hydrogen
125 atoms for halogens, or methyl, alkyl, or methoxy groups, in the
126 aromatic ring of the anilide moiety;
127 e. With or without substitution at the alpha or beta
128 position of the piperidine ring with alkyl, hydroxyl, or methoxy
129 groups;
130 f. With or without substitution of the benzene ring of the
131 anilide moiety for an aromatic heterocycle; and
132 g. With or without substitution of the piperidine ring for
133 a pyrrolidine ring, perhydroazepine ring, or azepine ring;
134
135 excluding, Alfentanil, Carfentanil, Fentanyl, and Sufentanil;
136 including, but not limited to:
137 (I) Acetyl-alpha-methylfentanyl.
138 (II) Alpha-methylfentanyl (N-[1-(alpha-methyl-betaphenyl)
139 ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4
140 (N-propanilido) piperidine).
141 (III) Alpha-methylthiofentanyl.
142 (IV) Benzylfentanyl.
143 (V) Beta-hydroxyfentanyl.
144 (VI) Beta-hydroxy-3-methylfentanyl.
145 (VII) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4
146 piperidyl]-N-phenylpropanamide).
147 (VIII) 3-Methylthiofentanyl.
148 (IX) Para-Fluorofentanyl.
149 (X) Thenylfentanyl or Thienyl fentanyl.
150 (XI) Thiofentanyl.
151 (XII) Acetylfentanyl.
152 (XIII) Butyrylfentanyl.
153 (XIV) Beta-Hydroxythiofentanyl.
154 (XV) Lofentanil.
155 (XVI) Ocfentanil.
156 (XVII) Ohmfentanyl.
157 (XVIII) Benzodioxolefentanyl.
158 (XIX) Furanyl fentanyl.
159 (XX) Pentanoyl fentanyl.
160 (XXI) Cyclopentyl fentanyl.
161 (XXII) Isobutyryl fentanyl.
162 (XXIII) Remifentanil.
163 63. Nitazene derivatives. Unless specifically excepted,
164 listed in another schedule, or contained within a pharmaceutical
165 product approved by the United States Food and Drug
166 Administration, any material, compound, mixture, or preparation,
167 including its salts, isomers, esters, or ethers, and salts of
168 isomers, esters, or ethers, whenever the existence of such salts
169 is possible within any of the following specific chemical
170 designations containing a benzimidazole ring with an ethylamine
171 substitution at the 1-position and a benzyl ring substitution at
172 the 2-position structure:
173 a. With or without substitution on the benzimidazole ring
174 with alkyl, alkoxy, carboalkoxy, amino, nitro, or aryl groups,
175 or halogens;
176 b. With or without substitution at the ethylamine amino
177 moiety with alkyl, dialkyl, acetyl, or benzyl groups, whether or
178 not further substituted in the ring system;
179 c. With or without inclusion of the ethylamine amino moiety
180 in a cyclic structure;
181 d. With or without substitution of the benzyl ring; or
182 e. With or without replacement of the benzyl ring with an
183 aromatic ring, including, but not limited to:
184 (I) Butonitazene.
185 (II) Clonitazene.
186 (III) Etodesnitazene.
187 (IV) Etonitazene.
188 (V) Flunitazene.
189 (VI) Isotodesnitazene.
190 (VII) Isotonitazene.
191 (VIII) Metodesnitazene.
192 (IX) Metonitazene.
193 (X) Nitazene.
194 (XI) N-Desethyl Etonitazene.
195 (XII) N-Desethyl Isotonitazene.
196 (XIII) N-Piperidino Etonitazene.
197 (XIV) N-Pyrrolidino Etonitazene.
198 (XV) Protonitazene.
199 Section 2. This act shall take effect July 1, 2023.